68Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma

被引:2
作者
Maserumule, Letjie C. [1 ]
Mokoala, Kgomotso M. G. [1 ]
van de Wiele, Christophe [1 ,2 ]
Popoola, Gbenga [3 ]
Hlongwa, Khanyisile N. [1 ]
Ndlovu, Honest [1 ]
Maes, Alex [1 ,4 ]
Vorster, Mariza [1 ,5 ]
Sathekge, Mike M. [1 ,5 ]
机构
[1] Univ Pretoria, Steve Biko Acad Hosp, Dept Nucl Med, ZA-0001 Pretoria, South Africa
[2] Univ Ghent, Dept Diagnost Sci, B-9000 Ghent, Belgium
[3] Lincolnshire NHS Partnership Fdn Trust, The Wolds, Discovery House, Lincoln LN1 1FS, England
[4] Katholieke Univ Leuven, Dept Morphol & Med Imaging, B-8500 Leuven, Belgium
[5] Steve Biko Acad Hosp, Nucl Med Res Infrastruct NuMeRI, ZA-0001 Pretoria, South Africa
关键词
prostate cancer; Ga-68-PSMA PET/CT; PSMA; racial differences; ACTIVE SURVEILLANCE; CANCER; RACE;
D O I
10.3390/biomedicines10040882
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostate adenocarcinoma (PCa) is a leading cause of mortality. Black males with high-risk PCa have a poorer prognosis compared to white males. Patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 and 2 PCa have little potential for metastases post radical prostatectomy. (68)Gallium prostate specific membrane antigen (Ga-68-PSMA) PET/CT imaging for metastatic PCa is superior to conventional imaging in staging high-risk PCa. No strong evidence is available to support imaging low-risk patients. We aimed to evaluate the value of Ga-68-PSMA PET/CT in black and white South African (BSA and WSA) males with GG1 and 2 PCa at initial staging. We evaluated 25 WSA and 123 BSA males. The image findings were correlated with prostate specific antigen (PSA). PSA levels significantly correlated with both primary tumor and whole-body PSMA-tumor volume (PSMA-TV) and were higher in BSA males. No differences were noted in the occurrence of metastases; however, PSA, seminal vesicle invasion and black race predicted metastases. Our findings suggest higher PSMA expression and tumor burden in BSA with histologically low-risk PCa, and future research with immunohistochemistry evaluation will be essential to confirm these findings.
引用
收藏
页数:9
相关论文
共 30 条
  • [1] [Anonymous], 2019, PROSTATE 2018, V876, P1
  • [2] 68Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement
    Basha, Mohammad Abd Alkhalik
    Hamed, Maged Abdel Galil
    Hussein, Omar
    El-Diasty, Tarek
    Abdelkhalek, Yasser Ibrahim
    Hussein, Yehia Omar
    Alasamer, Ahmed Fathy
    Mohamed, Heba A. E.
    El Deen, Dalia Salah
    Tantawy, Engy Fathy
    Metwally, Maha Ibrahim
    Zaitoun, Mohamed M. A.
    Aly, Sameh Abdelaziz
    Altohamy, Jehan Ibrahim
    Mohamed, Abd El Motaleb
    Afifi, Amira Hamed Mohamed
    Harb, Ola
    [J]. ABDOMINAL RADIOLOGY, 2019, 44 (07) : 2545 - 2556
  • [3] 68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
    Berger, I
    Annabattula, C.
    Lewis, J.
    Shetty, D., V
    Kam, J.
    Maclean, F.
    Arianayagam, M.
    Canagasingham, B.
    Ferguson, R.
    Khadra, M.
    Ko, R.
    Winter, M.
    Loh, H.
    Varol, C.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (02) : 204 - 211
  • [4] Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
    Bill-Axelson, Anna
    Holmberg, Lars
    Garmo, Hans
    Rider, Jennifer R.
    Taari, Kimmo
    Busch, Christer
    Nordling, Stig
    Haggman, Michael
    Andersson, Swen-Olof
    Spangberg, Anders
    Andren, Ove
    Palmgren, Juni
    Steineck, Gunnar
    Adami, Hans-Olov
    Johansson, Jan-Erik
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (10) : 932 - 942
  • [5] Active Surveillance for Low-Risk Prostate Cancer in Black Patients
    Butler, Santino
    Muralidhar, Vinayak
    Chavez, Janice
    Fullerton, Zoe
    Mahal, Aman
    Nezolosky, Michelle
    Vastola, Marie
    Zhao, Shuang G.
    D'Amico, Anthony V.
    Dess, Robert T.
    Feng, Felix Y.
    King, Martin T.
    Mouw, Kent W.
    Spratt, Daniel E.
    Quoc-Dien Trinh
    Nguyen, Paul L.
    Rebbeck, Timothy R.
    Mahal, Brandon A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21) : 2070 - 2072
  • [6] NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection
    Carroll, Peter H.
    Mohler, James L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 620 - 623
  • [7] 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
    Cytawa, Wojciech
    Seitz, Anna Katharina
    Kircher, Stefan
    Fukushima, Kazuhito
    Tran-Gia, Johannes
    Schirbel, Andreas
    Bandurski, Tomasz
    Lass, Piotr
    Krebs, Markus
    Polom, Wojciech
    Matuszewski, Marcin
    Wester, Hans-Juergen
    Buck, Andreas K.
    Kuebler, Hubert
    Lapa, Constantin
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 168 - 177
  • [8] Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
    Ebenhan, Thomas
    Vorster, Mariza
    Marjanovic-Painter, Biljana
    Wagener, Judith
    Suthiram, Janine
    Modiselle, Moshe
    Mokaleng, Brenda
    Zeevaart, Jan Rijn
    Sathekge, Mike
    [J]. MOLECULES, 2015, 20 (08) : 14860 - 14878
  • [9] A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
    Epstein, Jonathan I.
    Zelefsky, Michael J.
    Sjoberg, Daniel D.
    Nelson, Joel B.
    Egevad, Lars
    Magi-Galluzzi, Cristina
    Vickers, Andrew J.
    Parwani, Anil V.
    Reuter, Victor E.
    Fine, Samson W.
    Eastham, James A.
    Wiklund, Peter
    Han, Misop
    Reddy, Chandana A.
    Ciezki, Jay P.
    Nyberg, Tommy
    Klein, Eric A.
    [J]. EUROPEAN UROLOGY, 2016, 69 (03) : 428 - 435
  • [10] PET/MRI in prostate cancer: a systematic review and meta-analysis
    Evangelista, Laura
    Zattoni, Fabio
    Cassarino, Gianluca
    Artioli, Paolo
    Cecchin, Diego
    dal Moro, Fabrizio
    Zucchetta, Pietro
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (03) : 859 - 873